Harnessing real-world evidence in pharmacoeconomics: A comprehensive review
Real-world evidence (RWE) is increasingly recognized as a valuable resource in pharmacoeconomics, offering insights into the effectiveness, safety, and economic impact of healthcare interventions in routine clinical settings. This review highlights the growing significance of RWE beyond traditional...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2024-11-01
|
| Series: | Open Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/ohe-2023-0048 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846143513728647168 |
|---|---|
| author | Bhatia Nitish |
| author_facet | Bhatia Nitish |
| author_sort | Bhatia Nitish |
| collection | DOAJ |
| description | Real-world evidence (RWE) is increasingly recognized as a valuable resource in pharmacoeconomics, offering insights into the effectiveness, safety, and economic impact of healthcare interventions in routine clinical settings. This review highlights the growing significance of RWE beyond traditional clinical trials, focusing on its applications in healthcare decision-making. Key sources of RWE, such as electronic health records, claims data, registries, and observational studies, are explored alongside methodologies like retrospective cohort studies, case–control studies, and comparative effectiveness research. The review examines RWE’s role in assessing treatment effectiveness, estimating healthcare costs, evaluating long-term outcomes, and informing health technology assessments and reimbursement decisions. Challenges such as data quality, confounding factors, and generalizability are discussed with strategies for overcoming these limitations. Regulatory perspectives from agencies like the Food and Drug Administration and European Medicines Agency, as well as ethical and privacy considerations are also reviewed. Emerging trends, such as the integration of artificial intelligence and patient-generated data, offer new opportunities for enhancing the use of RWE in healthcare. The findings emphasize the importance of leveraging RWE to improve healthcare delivery, optimize resource allocation, and support value-based decision-making. |
| format | Article |
| id | doaj-art-89dbaabb89c440cbb9abd49e50a88167 |
| institution | Kabale University |
| issn | 2544-9826 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | De Gruyter |
| record_format | Article |
| series | Open Health |
| spelling | doaj-art-89dbaabb89c440cbb9abd49e50a881672024-12-02T12:04:40ZengDe GruyterOpen Health2544-98262024-11-015129530410.1515/ohe-2023-0048Harnessing real-world evidence in pharmacoeconomics: A comprehensive reviewBhatia Nitish0Department of Pharmacology, School of Pharmacy, Vishwakarma University, Pune, Maharashtra, IndiaReal-world evidence (RWE) is increasingly recognized as a valuable resource in pharmacoeconomics, offering insights into the effectiveness, safety, and economic impact of healthcare interventions in routine clinical settings. This review highlights the growing significance of RWE beyond traditional clinical trials, focusing on its applications in healthcare decision-making. Key sources of RWE, such as electronic health records, claims data, registries, and observational studies, are explored alongside methodologies like retrospective cohort studies, case–control studies, and comparative effectiveness research. The review examines RWE’s role in assessing treatment effectiveness, estimating healthcare costs, evaluating long-term outcomes, and informing health technology assessments and reimbursement decisions. Challenges such as data quality, confounding factors, and generalizability are discussed with strategies for overcoming these limitations. Regulatory perspectives from agencies like the Food and Drug Administration and European Medicines Agency, as well as ethical and privacy considerations are also reviewed. Emerging trends, such as the integration of artificial intelligence and patient-generated data, offer new opportunities for enhancing the use of RWE in healthcare. The findings emphasize the importance of leveraging RWE to improve healthcare delivery, optimize resource allocation, and support value-based decision-making.https://doi.org/10.1515/ohe-2023-0048real-world evidencepharmacoeconomicshealthcare decision-makingtreatment effectivenesshealth technology assessmentartificial intelligence |
| spellingShingle | Bhatia Nitish Harnessing real-world evidence in pharmacoeconomics: A comprehensive review Open Health real-world evidence pharmacoeconomics healthcare decision-making treatment effectiveness health technology assessment artificial intelligence |
| title | Harnessing real-world evidence in pharmacoeconomics: A comprehensive review |
| title_full | Harnessing real-world evidence in pharmacoeconomics: A comprehensive review |
| title_fullStr | Harnessing real-world evidence in pharmacoeconomics: A comprehensive review |
| title_full_unstemmed | Harnessing real-world evidence in pharmacoeconomics: A comprehensive review |
| title_short | Harnessing real-world evidence in pharmacoeconomics: A comprehensive review |
| title_sort | harnessing real world evidence in pharmacoeconomics a comprehensive review |
| topic | real-world evidence pharmacoeconomics healthcare decision-making treatment effectiveness health technology assessment artificial intelligence |
| url | https://doi.org/10.1515/ohe-2023-0048 |
| work_keys_str_mv | AT bhatianitish harnessingrealworldevidenceinpharmacoeconomicsacomprehensivereview |